This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
New Scientist
newscientist.com
did:plc:546qgaw5whiyfktyiyzv4z3p
A first-of-its-kind Guillain-Barré drug switches off part of immune system and could be approved for use next year.
https://www.newscientist.com/article/2582376-first-targeted-treatment-for-guillain-barre-syndrome-nears-approval/?utm_term=Autofeed&utm_medium=SOC&utm_source=Bluesky#Echobox=1785889203
2026-08-05T01:38:39.562Z